QAB2A Igm Elisa Kit

FDA 510(k) K020694 · Cheshire Diagnostics , Ltd.

Substantially Equivalent

510(k) numberK020694

Submission

Device name
QAB2A Igm Elisa Kit
Applicant
Cheshire Diagnostics , Ltd.
Cheshire, GB
Received
March 4, 2002
Decision date
April 19, 2002
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
MVS – Kit, Typing, Hla-Dqb
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5660
Specialty
Immunology

More from Cheshire Diagnostics , Ltd.

510(k)DeviceDecision
K021611QAB2A Igg Elisa Kit HRPMSV · Traditional 07/12/2002SE
K021610QAB2A Igm Elisa Kit HRPMSV · Traditional 07/12/2002SE
K021192Qaca Igg/Igm Elisa Kit HRPMID · Traditional 05/16/2002SE
K020695QAB2A Igg Elisa KitMSV · Traditional 04/19/2002SE
K020241Qaca Igg/Igm Elisa KitMID · Traditional 03/13/2002SE

Questions and answers

When was QAB2A Igm Elisa Kit cleared by the FDA?

QAB2A Igm Elisa Kit (K020694) received a 510(k) decision of Substantially Equivalent on April 19, 2002, 46 days after the submission was received.

What is the product code of K020694?

The FDA product code is MVS – Kit, Typing, Hla-Dqb, a Class II (moderate risk) device regulated under 21 CFR 866.5660.